175 related articles for article (PubMed ID: 19533752)
1. High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer.
Bergeron A; Picard V; LaRue H; Harel F; Hovington H; Lacombe L; Fradet Y
Int J Cancer; 2009 Sep; 125(6):1365-71. PubMed ID: 19533752
[TBL] [Abstract][Full Text] [Related]
2. MAGE-A9 mRNA and protein expression in bladder cancer.
Picard V; Bergeron A; Larue H; Fradet Y
Int J Cancer; 2007 May; 120(10):2170-7. PubMed ID: 17290406
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma.
Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M
Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095
[TBL] [Abstract][Full Text] [Related]
4. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
5. Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors.
Bellati F; Napoletano C; Tarquini E; Palaia I; Landi R; Manci N; Spagnoli G; Rughetti A; Panici PB; Nuti M
Eur J Cancer; 2007 Nov; 43(17):2621-7. PubMed ID: 17950595
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
[TBL] [Abstract][Full Text] [Related]
7. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
Han L; Jiang B; Wu H; Zhang S; Lu X
Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
[TBL] [Abstract][Full Text] [Related]
10. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
[TBL] [Abstract][Full Text] [Related]
11. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.
Mengus C; Schultz-Thater E; Coulot J; Kastelan Z; Goluza E; Coric M; Spagnoli GC; Hudolin T
Int J Cancer; 2013 May; 132(10):2459-63. PubMed ID: 23125074
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study.
Kocher T; Zheng M; Bolli M; Simon R; Forster T; Schultz-Thater E; Remmel E; Noppen C; Schmid U; Ackermann D; Mihatsch MJ; Gasser T; Heberer M; Sauter G; Spagnoli GC
Int J Cancer; 2002 Aug; 100(6):702-5. PubMed ID: 12209610
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of MAGE-A9 expression in patients with colorectal cancer.
Zhan W; Zhang Z; Zhang Y; Ma J; Wu T; Gu Y; Li Y; Yang J
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):239-45. PubMed ID: 26516058
[TBL] [Abstract][Full Text] [Related]
15. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma.
Brisam M; Rauthe S; Hartmann S; Linz C; Brands RC; Kübler AC; Rosenwald A; Müller-Richter UD
Oncol Rep; 2016 Apr; 35(4):1979-86. PubMed ID: 26820613
[TBL] [Abstract][Full Text] [Related]
16. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
17. Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder.
Xylinas E; Cha EK; Khani F; Kluth LA; Rieken M; Volkmer BG; Hautmann R; Küfer R; Chen YT; Zerbib M; Rubin MA; Scherr DS; Shariat SF; Robinson BD
J Urol; 2014 Mar; 191(3):830-41. PubMed ID: 23994370
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
[TBL] [Abstract][Full Text] [Related]
19. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]